Ensemble Therapeutics
Ensemble develops Ensemblins to treat diseases by addressing drug targets that are currently inaccessible with small molecule drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
€55—82m (Dealroom.co estimates Nov 2007.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$15.0m | Series A | ||
$15.0m | Series B | ||
Total Funding | €27.3m |